Cargando…
The Role of Pharmacogenetics in the Therapeutic Response to Thiopurines in the Treatment of Inflammatory Bowel Disease: A Systematic Review
This study focuses on the use of thiopurines for treating inflammatory bowel diseases (IBD). These drugs undergo enzymatic changes within the body, resulting in active and inactive metabolites that influence their therapeutic effects. The research examines the role of genetic polymorphisms in the en...
Autores principales: | Ribeiro, Aline C., Gerheim, Pâmela S. A. S., Chebli, Julio Maria Fonseca, Nascimento, Jorge Willian L., de Faria Pinto, Priscila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649589/ https://www.ncbi.nlm.nih.gov/pubmed/37959208 http://dx.doi.org/10.3390/jcm12216742 |
Ejemplares similares
-
Pharmacogenetics of thiopurines
por: Franca, Raffaella, et al.
Publicado: (2019) -
Pharmacogenetics of thiopurine therapy: from thiopurine S-methyltransferase to S-adenosylmethionine
por: Mlinarič-Raščan, Irena, et al.
Publicado: (2009) -
Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping
por: Kakuta, Yoichi, et al.
Publicado: (2017) -
Thiopurine Methyltransferase Activity and Thiopurine Metabolites in Inflammatory Bowel Disease
por: El-Matary, Wael
Publicado: (2020) -
Pharmacogenetics of Biological Agents Used in Inflammatory Bowel Disease: A Systematic Review
por: Lauro, Rita, et al.
Publicado: (2021)